Camlin Fine Sciences Announces Financial Results for FY 2026 and Key Management Appointments
Camlin Fine Sciences Limited announced that its Board of Directors held a meeting on Tuesday, May 26, 2026, approving the company's audited financial statements and key personnel changes for the financial year ended March 31, 2026.The Board approved the Audited Financial Statements (Consolidated and Standalone) and the Audited Financial Results (Consolidated and Standalone) for the quarter and year ended March 31, 2026.
The company also announced that the 33rd Annual General Meeting (AGM) is scheduled for Tuesday, August 11, 2026, at 10:00 a.m.
Financial Results Summary
The audited financial results for the year ended March 31, 2026, reflect significant changes in the company's financial profile. Key revenue metrics are presented below:Financial Results for the Quarter/Year Ended March 31, 2026 (Rs. in Lakh, except per share data)
| PARTICULARS | STANDALONE - Qtr Ended 31.03.26 (Audited) | STANDALONE - Year Ended 31.03.26 (Audited) | CONSOLIDATED - Qtr Ended 31.03.26 (Audited) | CONSOLIDATED - Year Ended 31.03.26 (Audited) |
|---|---|---|---|---|
| Revenue from operations | 18,351.65 | 83,791.82 | 42,481.12 | 172,330.81 |
| Total income | 19,881.84 | 87,286.93 | 44,872.34 | 175,210.04 |
| Total Expenses | 21,284.32 | 91,069.20 | 44,74202 | 176,028.85 |
| Profit/ (Loss) for the period (after exceptional items) | (564.95) | (3,296.62) | 8,627.73 | 2,354.32 |
The statutory auditor, M/s Kalyaniwalla & Mistry LLP, Chartered Accountants, issued reports with an unmodified opinion on the Audited Standalone and Audited Consolidated Financial Statements for the financial year ended March 31, 2026.
The audited financial results and related details are available for review on the company's website.
Operational and Management Updates
The Board meeting approved several key operational and management appointments for the financial year ending March 31, 2027.The Board approved the following appointments based on recommendations from the Audit Committee and the Nomination and Remuneration Committee:
- Cost Auditor: M/s ABK & Associates, Cost Accountants, appointed for the financial year ending March 31, 2027.
- Internal Auditor: M/s Mahajan & Aibara, Chartered Accountants, appointed for the financial year ending March 31, 2027.
In terms of key managerial personnel, the Board approved changes effective August 18, 2026:
- Mr. Pankaj Pandey was appointed as Chief Financial Officer (CFO) and Key Managerial Personnel.
- Upon Mr. Pandey's joining as CFO, Mr. Santosh Parab will be re-designated as President - Strategy and Global CFO.
Corporate Actions and Next Steps
The company confirmed that the 33rd Annual General Meeting (AGM) will be held on Tuesday, August 11, 2026.CAMLINFINE Stock Price Movement
Shares of Camlin Fine Sciences Limited today slipped by 1.00% to settle at ₹121.56. The stock traded on a volume of 1.38 million shares, suggesting significant post-session selling pressure.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.